NVCT- Nuvectis Pharma, Inc.

Over the past 90 days, insiders at Nuvectis Pharma, Inc. (NVCT) have been net buyers, picking up 62,500 shares worth roughly $1.2M on balance.

Classified under Biotechnology (Health Care sector), NVCT's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Bentsur Ron	3.69M	$82.55M	-
10%	Mosseri Marlio Charles	3.19M	$71.32M	-
Other	Poradosu Enrique	1.81M	$40.43M	-
Other	Shemesh Shay	1.79M	$40.13M	-
VP	Carson Michael J.	200.1K	$4.48M	-

Buys and sells only

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 21, 2023	Bentsur Ron64	Chairman &CEO	Buy	335	$14.92	$4,997.85	-	-39.6%	-55.3%
Jul 21, 2023	Mosseri Marlio Charles46	10% Owner	Buy	8,238	$14.47	$119,224.44	+0.2%	-39.6%	-55.3%
Jul 19, 2023	Bentsur Ron64	Chairman &CEO	Buy	200	$14.33	$2,866.00	-	-34.2%	-55.0%
Jul 19, 2023	Mosseri Marlio Charles46	10% Owner	Buy	8,000	$14.84	$118,720.00	+0.3%	-34.2%	-55.0%
Jul 18, 2023	Mosseri Marlio Charles46	10% Owner	Buy	9,149	$14.84	$135,771.16	+0.4%	-27.1%	-54.0%
Jul 14, 2023	Bentsur Ron64	Chairman &CEO	Buy	260	$15.52	$4,035.40	-	-36.1%	-56.0%
Jul 12, 2023	Mosseri Marlio Charles46	10% Owner	Buy	3,285	$15.09	$49,570.65	+0.1%	-28.7%	-57.5%
Jul 11, 2023	Mosseri Marlio Charles46	10% Owner	Buy	10,000	$15.36	$153,600.00	+0.4%	-29.0%	-59.3%
Jul 7, 2023	Mosseri Marlio Charles46	10% Owner	Buy	8,948	$15.19	$135,920.12	+0.4%	-28.7%	-59.4%
Jul 6, 2023	Mosseri Marlio Charles46	10% Owner	Buy	3,179	$15.01	$47,716.79	+0.1%	-27.5%	-59.3%